Cirius withdraws $86M IPO as vaunted 'Year of NASH' draws to brutal close

Cirius Therapeutics didn’t wait for the government shutdown to end before it filed its IPO in January. It was, as JP Morgan analysts had predicted the month prior, “The Year of NASH” and Cirius believed their Phase II program could raise $86 million.